262 related articles for article (PubMed ID: 28776445)
1. Inhibition of dengue virus replication by novel inhibitors of RNA-dependent RNA polymerase and protease activities.
Pelliccia S; Wu YH; Coluccia A; La Regina G; Tseng CK; Famiglini V; Masci D; Hiscott J; Lee JC; Silvestri R
J Enzyme Inhib Med Chem; 2017 Dec; 32(1):1091-1101. PubMed ID: 28776445
[TBL] [Abstract][Full Text] [Related]
2. Insights on Dengue and Zika NS5 RNA-dependent RNA polymerase (RdRp) inhibitors.
Nascimento IJDS; Santos-Júnior PFDS; Aquino TM; Araújo-Júnior JX; Silva-Júnior EFD
Eur J Med Chem; 2021 Nov; 224():113698. PubMed ID: 34274831
[TBL] [Abstract][Full Text] [Related]
3. Effects of NS2B-NS3 protease and furin inhibition on West Nile and Dengue virus replication.
Kouretova J; Hammamy MZ; Epp A; Hardes K; Kallis S; Zhang L; Hilgenfeld R; Bartenschlager R; Steinmetzer T
J Enzyme Inhib Med Chem; 2017 Dec; 32(1):712-721. PubMed ID: 28385094
[TBL] [Abstract][Full Text] [Related]
4. Quassinoids from Eurycoma longifolia with antiviral activities by inhibiting dengue virus replication.
He X; Zheng Y; Tian C; Wen T; Yang T; Yu J; Fang X; Fan C; Liu J; Yu L
Phytomedicine; 2023 Feb; 110():154650. PubMed ID: 36649670
[TBL] [Abstract][Full Text] [Related]
5. Two RNA Tunnel Inhibitors Bind in Highly Conserved Sites in Dengue Virus NS5 Polymerase: Structural and Functional Studies.
Arora R; Liew CW; Soh TS; Otoo DA; Seh CC; Yue K; Nilar S; Wang G; Yokokawa F; Noble CG; Chen YL; Shi PY; Lescar J; Smith TM; Benson TE; Lim SP
J Virol; 2020 Nov; 94(24):. PubMed ID: 32907977
[TBL] [Abstract][Full Text] [Related]
6. Non-nucleoside Inhibitors of Zika Virus RNA-Dependent RNA Polymerase.
Gharbi-Ayachi A; Santhanakrishnan S; Wong YH; Chan KWK; Tan ST; Bates RW; Vasudevan SG; El Sahili A; Lescar J
J Virol; 2020 Oct; 94(21):. PubMed ID: 32796069
[TBL] [Abstract][Full Text] [Related]
7. Functionalized 2,1-benzothiazine 2,2-dioxides as new inhibitors of Dengue NS5 RNA-dependent RNA polymerase.
Cannalire R; Tarantino D; Astolfi A; Barreca ML; Sabatini S; Massari S; Tabarrini O; Milani M; Querat G; Mastrangelo E; Manfroni G; Cecchetti V
Eur J Med Chem; 2018 Jan; 143():1667-1676. PubMed ID: 29137867
[TBL] [Abstract][Full Text] [Related]
8. [1,2,4]Triazolo[1,5-a]pyrimidine derivative (Mol-5) is a new NS5-RdRp inhibitor of DENV2 proliferation and DENV2-induced inflammation.
Wan YH; Wu WY; Guo SX; He SJ; Tang XD; Wu XY; Nandakumar KS; Zou M; Li L; Chen XG; Liu SW; Yao XG
Acta Pharmacol Sin; 2020 May; 41(5):706-718. PubMed ID: 31729469
[TBL] [Abstract][Full Text] [Related]
9. A quinoline compound inhibits the replication of dengue virus serotypes 1-4 in Vero cells.
Beesetti H; Tyagi P; Medapi B; Krishna VS; Sriram D; Khanna N; Swaminathan S
Antivir Ther; 2018; 23(5):385-394. PubMed ID: 29583121
[TBL] [Abstract][Full Text] [Related]
10. Characterization of the activity of 2'-C-methylcytidine against dengue virus replication.
Lee JC; Tseng CK; Wu YH; Kaushik-Basu N; Lin CK; Chen WC; Wu HN
Antiviral Res; 2015 Apr; 116():1-9. PubMed ID: 25614455
[TBL] [Abstract][Full Text] [Related]
11. Discovery of Potent Non-nucleoside Inhibitors of Dengue Viral RNA-Dependent RNA Polymerase from Fragment Screening and Structure-Guided Design.
Lim SP; Noble CG; Nilar S; Shi PY; Yokokawa F
Adv Exp Med Biol; 2018; 1062():187-198. PubMed ID: 29845534
[TBL] [Abstract][Full Text] [Related]
12. Cordycepin Inhibits Virus Replication in Dengue Virus-Infected Vero Cells.
Panya A; Songprakhon P; Panwong S; Jantakee K; Kaewkod T; Tragoolpua Y; Sawasdee N; Lee VS; Nimmanpipug P; Yenchitsomanus PT
Molecules; 2021 May; 26(11):. PubMed ID: 34071102
[TBL] [Abstract][Full Text] [Related]
13. Exploring the therapeutic potential of DV-B-120 as an inhibitor of dengue virus infection.
Huang Y-J; Cheng T-L; Wang Y-T; Chen C-S; Leu Y-L; Chang C-S; Ho C-H; Chao S-W; Li C-T; Chuang C-H
J Virol; 2024 Apr; 98(4):e0125823. PubMed ID: 38546211
[TBL] [Abstract][Full Text] [Related]
14. Discovery of antiviral molecules for dengue: In silico search and biological evaluation.
Cabarcas-Montalvo M; Maldonado-Rojas W; Montes-Grajales D; Bertel-Sevilla A; Wagner-Döbler I; Sztajer H; Reck M; Flechas-Alarcon M; Ocazionez R; Olivero-Verbel J
Eur J Med Chem; 2016 Mar; 110():87-97. PubMed ID: 26807547
[TBL] [Abstract][Full Text] [Related]
15. Nucleoside Analogs with Selective Antiviral Activity against Dengue Fever and Japanese Encephalitis Viruses.
Zandi K; Bassit L; Amblard F; Cox BD; Hassandarvish P; Moghaddam E; Yueh A; Libanio Rodrigues GO; Passos I; Costa VV; AbuBakar S; Zhou L; Kohler J; Teixeira MM; Schinazi RF
Antimicrob Agents Chemother; 2019 Jul; 63(7):. PubMed ID: 31061163
[TBL] [Abstract][Full Text] [Related]
16. Small molecule pan-dengue and West Nile virus NS3 protease inhibitors.
Cregar-Hernandez L; Jiao GS; Johnson AT; Lehrer AT; Wong TA; Margosiak SA
Antivir Chem Chemother; 2011 May; 21(5):209-17. PubMed ID: 21566267
[TBL] [Abstract][Full Text] [Related]
17. Discovery of novel cyclic peptide inhibitors of dengue virus NS2B-NS3 protease with antiviral activity.
Takagi Y; Matsui K; Nobori H; Maeda H; Sato A; Kurosu T; Orba Y; Sawa H; Hattori K; Higashino K; Numata Y; Yoshida Y
Bioorg Med Chem Lett; 2017 Aug; 27(15):3586-3590. PubMed ID: 28539222
[TBL] [Abstract][Full Text] [Related]
18. Antiviral activity of four types of bioflavonoid against dengue virus type-2.
Zandi K; Teoh BT; Sam SS; Wong PF; Mustafa MR; Abubakar S
Virol J; 2011 Dec; 8():560. PubMed ID: 22201648
[TBL] [Abstract][Full Text] [Related]
19. Cyclooxygenase-2 facilitates dengue virus replication and serves as a potential target for developing antiviral agents.
Lin CK; Tseng CK; Wu YH; Liaw CC; Lin CY; Huang CH; Chen YH; Lee JC
Sci Rep; 2017 Mar; 7():44701. PubMed ID: 28317866
[TBL] [Abstract][Full Text] [Related]
20. Perspectives on the current antiviral developments towards RNA-dependent RNA polymerase (RdRp) and methyltransferase (MTase) domains of dengue virus non-structural protein 5 (DENV-NS5).
Sreekanth GP
Eur J Med Chem; 2023 Aug; 256():115416. PubMed ID: 37159959
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
